NCT00699556 - Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Alcohol Drinking

Interventions

DRUG

21mg transdermal nicotine patch (Nicoderm CQ)

21mg transdermal nicotine patch

DRUG

1mg nicotine nasal spray

two 0.5mg/sprays, one to each nostril (dose = 1mg) The nicotine nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital. It is similar in concentration to Nicotrol.

DRUG

placebo nasal spray

saline combined with capsaicin to mimic the brief nasal irritation from active nicotine spray The placebo nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital.

Trial Locations (1)

06519

Connecticut Mental Health Center & Yale-New Haven Hospital, New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER